Avancès C - Search Results

1

Liver metastases in prostate carcinoma: clinical characteristics and outcome.

Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S. Pouessel D, et al. Among authors: avances c. BJU Int. 2007 Apr;99(4):807-11. doi: 10.1111/j.1464-410X.2006.06663.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155968

2

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.

Culine S, El Demery M, Lamy PJ, Iborra F, Avancès C, Pinguet F. Culine S, et al. Among authors: avances c. J Urol. 2007 Sep;178(3 Pt 1):844-8; discussion 848. doi: 10.1016/j.juro.2007.05.044. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631339 Clinical Trial.

3

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X. Culine S, et al. Among authors: avances c. Am J Clin Oncol. 2006 Apr;29(2):148-52. doi: 10.1097/01.coc.0000203753.74851.d5. Am J Clin Oncol. 2006. PMID: 16601433 Clinical Trial.

4

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?].

El Demery M, Pouessel D, Avancès C, Iborra F, Rebillard X, Faix A, Ségui B, Delbos O, Ayuso D, Culine S. El Demery M, et al. Among authors: avances c. Prog Urol. 2006 Jun;16(3):320-3. Prog Urol. 2006. PMID: 16821344 French.

5

Prompt resolution of acute disseminated intravascular coagulation with docetaxel and cisplatin in hormone refractory prostate cancer.

Avancès C, Jacot W, Sénesse P, Culine S. Avancès C, et al. J Urol. 2002 Oct;168(4 Pt 1):1496. doi: 10.1016/S0022-5347(05)64487-4. J Urol. 2002. PMID: 12352431 No abstract available.

6

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L. Clapé C, et al. Among authors: avances c. PLoS One. 2009 Oct 26;4(10):e7542. doi: 10.1371/journal.pone.0007542. PLoS One. 2009. PMID: 19855844 Free PMC article.

7

Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.

Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L. Fritz V, et al. Among authors: avances c. Mol Cancer Ther. 2010 Jun;9(6):1740-54. doi: 10.1158/1535-7163.MCT-09-1064. Epub 2010 Jun 8. Mol Cancer Ther. 2010. PMID: 20530718 Free PMC article.

8

Prognostic factors for first recurrence in patients with retroperitoneal sarcoma.

Avancès C, Mottet N, Mahatmat A, Chapuis E, Serre I, Culine S. Avancès C, et al. Urol Oncol. 2006 Mar-Apr;24(2):94-6. doi: 10.1016/j.urolonc.2005.09.004. Urol Oncol. 2006. PMID: 16520270

9

[What about lombo-aortic curage in the treatment of testicle cancer?].

Iborra F, Avances C, Culine S, Houlgatte A, Mottete N. Iborra F, et al. Among authors: avances c. Ann Urol (Paris). 2007 Jun;41(3):116-26. doi: 10.1016/j.anuro.2007.04.002. Ann Urol (Paris). 2007. PMID: 18260272 Review. French.

10

[Prostate cancer and acute disseminated intravascular coagulation. Therapeutic management based on three cases].

Avances C, Oumaya C, Granger V, Dubon O, Gris JC, Culine S, Costa P. Avances C, et al. Prog Urol. 2003 Apr;13(2):308-12. Prog Urol. 2003. PMID: 12765072 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page